We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.39B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.37B
AUM Growth
+$38.4M
Cap. Flow
-$84.5M
Cap. Flow %
-3.57%
Top 10 Hldgs %
15.21%
Holding
300
New
21
Increased
93
Reduced
145
Closed
17

Top Buys

1
DCI icon
Donaldson
DCI
+$28.8M
2
COR icon
Cencora
COR
+$28.5M
3
RPM icon
RPM International
RPM
+$28M
4
ABT icon
Abbott
ABT
+$27.2M
5
STLA icon
Stellantis
STLA
+$11.1M

Top Sells

1
GPN icon
Global Payments
GPN
+$29.6M
2
CRM icon
Salesforce
CRM
+$27.8M
3
LMT icon
Lockheed Martin
LMT
+$22.9M
4
MRK icon
Merck
MRK
+$20.9M
5
PPLI
People Inc
PPLI
+$18.3M

Sector Composition

1 Technology 26.97%
2 Healthcare 16.16%
3 Industrials 10.26%
4 Financials 8.62%
5 Consumer Discretionary 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBAC icon
226
SBA Communications
SBAC
$19.8B
$260K 0.01%
935
-31
-3% -$8.21K
PLD icon
227
Prologis
PLD
$139B
$259K 0.01%
2,445
-127
-5% -$12.9K
SPY icon
228
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$254K 0.01%
642
– –
CONE
229
DELISTED
CyrusOne Inc Common Stock
CONE
$249K 0.01%
3,680
-154
-4% -$10.7K
DEA
230
Easterly Government Properties
DEA
$1.18B
$247K 0.01%
4,774
-181
-4% -$9.97K
VWO icon
231
Vanguard FTSE Emerging Markets ETF
VWO
$118B
$244K 0.01%
4,694
– –
CNP icon
232
CenterPoint Energy
CNP
$28.2B
$242K 0.01%
10,696
+277
+3% +$5.91K
IBM icon
233
IBM
IBM
$198B
$239K 0.01%
1,874
+34
+2% +$4.07K
INGR icon
234
Ingredion
INGR
$6.44B
$230K 0.01%
2,561
– –
VZ icon
235
Verizon
VZ
$183B
$229K 0.01%
3,945
+88
+2% +$4.97K
GILD icon
236
Gilead Sciences
GILD
$167B
$201K 0.01%
+3,114
New +$201K
CRM icon
237
Salesforce
CRM
$140B
– –
-124,884
Closed -$27.8M
AGNT
238
AGNT Inc
AGNT
$741M
– –
-39,480
Closed -$1.25M
GEO icon
239
The GEO Group
GEO
$3.91B
– –
-29,385
Closed -$260K
GPN icon
240
Global Payments
GPN
$21.5B
– –
-137,527
Closed -$29.6M
HQY icon
241
HealthEquity
HQY
$8.12B
– –
-17,295
Closed -$1.21M
LEA icon
242
Lear
LEA
$7.08B
– –
-2,034
Closed -$323K
LMT icon
243
Lockheed Martin
LMT
$118B
– –
-64,436
Closed -$22.9M
NVS icon
244
Novartis
NVS
$294B
– –
-98,099
Closed -$9.26M
QDEL icon
245
QuidelOrtho
QDEL
$1.19B
– –
-4,333
Closed -$778K
RTX icon
246
RTX Corp
RTX
$262B
– –
-3,468
Closed -$248K
UI icon
247
Ubiquiti
UI
$33B
– –
-4,198
Closed -$1.17M
EPAY
248
DELISTED
Bottomline Technologies Inc
EPAY
– –
-17,987
Closed -$949K
KL
249
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
– –
-197,721
Closed -$8.16M
RP
250
DELISTED
RealPage, Inc.
RP
– –
-14,038
Closed -$1.23M
7 8 9
10
11

Similar funds

MAS
Meeder Advisory Services Dublin, Ohio $2.39B AUM 23.78% 1-Year Est. Return
FHC
First Horizon Corporation Memphis, Tennessee $2.39B AUM
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.39B AUM 17.35% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
CIP
Cornerstone Investment Partners Atlanta, Georgia $2.38B AUM 32.49% 1-Year Est. Return
RAM
RWC Asset Management London, United Kingdom $2.4B AUM 29.54% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Renaissance Group's Q1 2021 Portfolio in Review

As of Q1 2021, Renaissance Group held 300 positions worth $2.37B, up 1.7% from $2.33B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Renaissance Group withdrew a net $84.5M in Q1 2021, closing 17 positions and reducing 145 holdings. Its most notable exit was Global Payments, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Renaissance Group opened a new position in Donaldson worth $28M.

  • Renaissance Group's largest Q1 2021 buy was Donaldson: 481,963 shares worth $28M.
  • Renaissance Group added most to Vertex Pharmaceuticals in Q1 2021, an estimated $5.17M increase.
  • Renaissance Group's biggest Q1 2021 reduction was Merck, cutting an estimated $20.9M.
  • Renaissance Group fully exited Global Payments in Q1 2021, selling an estimated $29.6M.
  • Renaissance Group's ten largest holdings make up 15% of its $2.37B portfolio in Q1 2021.
  • Renaissance Group opened 21 new positions and closed 17 in Q1 2021.
  • Renaissance Group's portfolio value rose 1.7% quarter-over-quarter to $2.37B.

Based on Renaissance Group's 13F filing for Q1 2021, filed 13 May 2021.